Search details
1.
Lysophagy protects against propagation of α-synuclein aggregation through ruptured lysosomal vesicles.
Proc Natl Acad Sci U S A
; 121(1): e2312306120, 2024 Jan 02.
Article
in English
| MEDLINE | ID: mdl-38147546
2.
Phosphatidylinositol-3,4,5-trisphosphate interacts with alpha-synuclein and initiates its aggregation and formation of Parkinson's disease-related fibril polymorphism.
Acta Neuropathol
; 145(5): 573-595, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36939875
3.
Involvement of Mitochondria in Parkinson's Disease.
Int J Mol Sci
; 24(23)2023 Dec 01.
Article
in English
| MEDLINE | ID: mdl-38069350
4.
Neuropathology of α-synuclein in Parkinson's disease.
Neuropathology
; 42(2): 93-103, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-35362115
5.
Parkinson's disease is a type of amyloidosis featuring accumulation of amyloid fibrils of α-synuclein.
Proc Natl Acad Sci U S A
; 116(36): 17963-17969, 2019 09 03.
Article
in English
| MEDLINE | ID: mdl-31427526
6.
Structurally distinct α-synuclein fibrils induce robust parkinsonian pathology.
Mov Disord
; 35(2): 256-267, 2020 02.
Article
in English
| MEDLINE | ID: mdl-31643109
7.
Parkinson's disease and iron.
J Neural Transm (Vienna)
; 127(2): 181-187, 2020 02.
Article
in English
| MEDLINE | ID: mdl-32025811
8.
Gene therapy targeting mitochondrial pathway in Parkinson's disease.
J Neural Transm (Vienna)
; 124(2): 193-207, 2017 02.
Article
in English
| MEDLINE | ID: mdl-27638713
9.
Disturbed Mitochondria-Lysosome Crosstalk in GBA1-Associated Parkinson's Disease.
Mov Disord
; 36(8): 1792, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34196414
10.
Decreased hepatic enzymes reflect the decreased vitamin B6 levels in Parkinson's disease patients.
Pharmacol Res Perspect
; 12(1): e1174, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38287715
11.
Two-step screening method to identify α-synuclein aggregation inhibitors for Parkinson's disease.
Sci Rep
; 12(1): 351, 2022 01 10.
Article
in English
| MEDLINE | ID: mdl-35013421
12.
Go-sha-jinki-Gan Alleviates Inflammation in Neurological Disorders via p38-TNF Signaling in the Central Nervous System.
Neurotherapeutics
; 18(1): 460-473, 2021 01.
Article
in English
| MEDLINE | ID: mdl-33083995
13.
Alternative mitochondrial quality control mediated by extracellular release.
Autophagy
; 17(10): 2962-2974, 2021 10.
Article
in English
| MEDLINE | ID: mdl-33218272
14.
Amido-bridged nucleic acid (AmNA)-modified antisense oligonucleotides targeting α-synuclein as a novel therapy for Parkinson's disease.
Sci Rep
; 9(1): 7567, 2019 05 21.
Article
in English
| MEDLINE | ID: mdl-31110191
15.
Single injection of sustained-release prostacyclin analog ONO-1301-MS ameliorates hypoxic toxicity in the murine model of amyotrophic lateral sclerosis.
Sci Rep
; 9(1): 5252, 2019 03 27.
Article
in English
| MEDLINE | ID: mdl-30918303
16.
A refined concept: α-synuclein dysregulation disease.
Neurochem Int
; 119: 84-96, 2018 10.
Article
in English
| MEDLINE | ID: mdl-29305061
17.
New 5-Aryl-Substituted 2-Aminobenzamide-Type HDAC Inhibitors with a Diketopiperazine Group and Their Ameliorating Effects on Ischemia-Induced Neuronal Cell Death.
Sci Rep
; 8(1): 1400, 2018 01 23.
Article
in English
| MEDLINE | ID: mdl-29362442
18.
Gene therapy for neurological disorders.
Expert Opin Biol Ther
; 16(2): 143-59, 2016.
Article
in English
| MEDLINE | ID: mdl-26642082
19.
A novel histone deacetylase 1 and 2 isoform-specific inhibitor alleviates experimental Parkinson's disease.
Neurobiol Aging
; 37: 103-116, 2016 Jan.
Article
in English
| MEDLINE | ID: mdl-26545632
20.
Synchrotron FTIR micro-spectroscopy for structural analysis of Lewy bodies in the brain of Parkinson's disease patients.
Sci Rep
; 5: 17625, 2015 Dec 01.
Article
in English
| MEDLINE | ID: mdl-26621077